×

A Conversation With King Pharma CEO Brian Markison

Drug developer King Pharmaceuticals said Thursday its third-quarter profit was cut in half by charges for related to its $1.6 billion buyout of rival Alpharma.

Still, King topped Wall Street forecasts, with revenue gaining ground from the addition of Alpharma's animal health unit.

King earned $42.5 million, or 17 cents per share, compared with profit of $82.5 million, or 34 cents per share, during the same period a year prior. Revenue rose 19 percent to $463.3 million from $388.4 million.

However, revenue from branded drugs fell 6 percent to $283 million in the quarter, due primarily to generic competition for the blood-pressure medication Altace, and lower sales of the bleeding-control drug Thrombin-JMI.

How should you game this stock? Before you make a trade check out our interview with CEO Brian Markison.


______________________________________________________
Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to fastmoney@cnbc.com.

Trader disclosure: On November 5th, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Adami Owns (AGU), (BTU), (C), (GS), (INTC), (MSFT), (NUE); Terranova Owns (GS), (OIH), (CAM), (MA), (JOYG), (RIMM); Najarian Owns (LAZ), Is Short (LAZ) Calls, Owns (LAZ) Puts; Najarian Owns (RIMM) Call Spread; Najarian Owns (SBUX), Is Short (SBUX) Calls; Najarian Owns (UUP) Calls; Najarian Owns (YHOO), (YHOO) Puts; Najarian Owns (ESI) Calls; Grasso Owns (AAPL), (ABK), (ASTM), (BA), (BAC), (C), (COST), (CSCO), (FAZ), (PFE), (PRST), (WMT), (V)

For Joe Terranova
Terranova Works For (VRTS)
Terranova Is Chief Market Strategist Of Virtus Investment Partners, Ltd.
Virtus Investment Partners Owns More Than 1% Of (CLB)
Virtus Investment Partners Owns More Than 1% Of (DLR)
Virtus Investment Partners Owns More Than 1% Of (EXR)
Virtus Investment Partners Owns More Than 1% Of (IGE)
Virtus Investment Partners Owns More Than 1% Of (XLY)
Virtus Investment Partners Owns More Than 1% Of (DBC)
Virtus Investment Partners Owns More Than 1% Of (DBV)
Virtus Investment Partners Owns More Than 1% Of (UA)

For Steve Grasso
Stuart Frankel Corp. And/Or Partners Own (AIZ)
Stuart Frankel Corp. And/Or Partners Own (CMCSK)
Stuart Frankel Corp. And/Or Partners Own (CUBA)
Stuart Frankel Corp. And/Or Partners Own (DVN)
Stuart Frankel Corp. And/Or Partners Own (GERN)
Stuart Frankel Corp. And/Or Partners Own (HSPO)
Stuart Frankel Corp. And/Or Partners Own (NWS.A)
Stuart Frankel Corp. And/Or Partners Own (NXST)
Stuart Frankel Corp. And/Or Partners Own (NYX)
Stuart Frankel Corp. And/Or Partners Own (PDE)
Stuart Frankel Corp. And/Or Partners Own (PRST)
Stuart Frankel Corp. And/Or Partners Own (RDC)
Stuart Frankel Corp. And/Or Partners Own (ROK)
Stuart Frankel Corp. And/Or Partners Own (TLM)
Stuart Frankel Corp. And/Or Partners Own (XRX)
Stuart Frankel Corp. And/Or Partners Own (SDS)
Stuart Frankel Corp. And/Or Partners Are Short (QQQQ)
Stuart Frankel Corp. And/Or Partners Are Short (CL)


CNBC.com with wires